OpenBilldrug price receipt

NADAC week of 2026-10-14

HYDRALAZINE 50 MG TABLET

For 30 tablets

Pharmacies pay

$1.34 filed

30 × $0.04454 per EA

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D paid

$2.66 filed

30 × $0.0887 per EA, Part D average

Medicare's price is not your price.

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18


The spread

2.0× estimated

Medicare paid 2.0× what pharmacies pay.

Part D averages every strength and form sold under “Hydralazine HCl*” / “Hydralazine HCl” into one figure, so it is not specific to this NDC.

OpenBill calculation · DSD_PTD_RY26_P04_V10_DY24_BGM.csv + nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17) · Part D 2024-01-01 to 2024-12-31 (file of 2026-06-25, retrieved 2026-10-18)

Cost-plus estimate

$6.54 estimated

$1.34 + $0.20 (15%) + $5.00 fee per fill = $6.54

This is a model, not a price any pharmacy quoted. Shipping is not included. For a pack this cheap, the $5.00 fee is most of the estimate. How it is worked out

OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)

Open the interactive card Change the quantity, type what you were charged, and see every record in full.

What it is

HYDRALAZINE 50 MG TABLET is how the CMS NADAC file names this product. The FDA NDC Directory lists it as hydralazine hydrochloride.

FDA gives its dosage form as “tablet” and “tablet, film coated” and its route as oral.

FDA lists 11 labelers (the companies named on the label) for its NDCs, among them Major Pharmaceuticals, Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. and Camber Pharmaceuticals, Inc.

FDA’s Established Pharmacologic Class for it is Arteriolar Vasodilator.

The NADAC file of 2026-10-14 prices it under 21 NDCs (National Drug Codes); the FDA directory lists 17 of them.

NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $1.34 for 30 tablets (30 × $0.04454 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation code for it: 1, calculated from the most recently completed pharmacy survey.

The 11 labelers

LabelerNDCsPharmacies pay per unit
Camber Pharmaceuticals, Inc.2$0.04454 per EA filed
Exelan Pharmaceuticals Inc.2$0.04454 per EA filed
Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.2$0.04454 per EA filed
ScieGen Pharmaceuticals, Inc.2$0.04454 per EA filed
Strides Pharma Science Limited2$0.04454 per EA filed
Teva Pharmaceuticals USA, Inc.2$0.04454 per EA filed
American Health Packaging1$0.04454 per EA filed
Chartwell RX, LLC1$0.04454 per EA filed
Major Pharmaceuticals1$0.04454 per EA filed
Modavar Pharmaceuticals LLC1$0.04454 per EA filed
Mylan Institutional Inc.1$0.04454 per EA filed
Not listed as a package in the FDA directory4$0.04454 per EA filed
All 21 NDCs, with labeler and price
  • 00904-7449-61 · Major Pharmaceuticals · $0.04454 per EA · eff. 2026-09-23 filed
  • 23155-0003-01 · not listed as a package in the FDA directory · $0.04454 per EA · eff. 2026-09-23 filed
  • 23155-0003-10 · not listed as a package in the FDA directory · $0.04454 per EA · eff. 2026-09-23 filed
  • 23155-0834-01 · Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. · $0.04454 per EA · eff. 2026-09-23 filed
  • 23155-0834-10 · Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. · $0.04454 per EA · eff. 2026-09-23 filed
  • 31722-0521-01 · Camber Pharmaceuticals, Inc. · $0.04454 per EA · eff. 2026-09-23 filed
  • 31722-0521-10 · Camber Pharmaceuticals, Inc. · $0.04454 per EA · eff. 2026-09-23 filed
  • 50111-0328-01 · Teva Pharmaceuticals USA, Inc. · $0.04454 per EA · eff. 2026-09-23 filed
  • 50111-0328-03 · Teva Pharmaceuticals USA, Inc. · $0.04454 per EA · eff. 2026-09-23 filed
  • 50228-0184-01 · ScieGen Pharmaceuticals, Inc. · $0.04454 per EA · eff. 2026-09-23 filed
  • 50228-0184-10 · ScieGen Pharmaceuticals, Inc. · $0.04454 per EA · eff. 2026-09-23 filed
  • 51079-0076-01 · not listed as a package in the FDA directory · $0.04454 per EA · eff. 2026-09-23 filed
  • 51079-0076-20 · Mylan Institutional Inc. · $0.04454 per EA · eff. 2026-09-23 filed
  • 60687-0833-01 · American Health Packaging · $0.04454 per EA · eff. 2026-09-23 filed
  • 60687-0833-11 · not listed as a package in the FDA directory · $0.04454 per EA · eff. 2026-09-23 filed
  • 62135-0581-12 · Chartwell RX, LLC · $0.04454 per EA · eff. 2026-09-23 filed
  • 64380-0735-06 · Strides Pharma Science Limited · $0.04454 per EA · eff. 2026-09-23 filed
  • 64380-0735-08 · Strides Pharma Science Limited · $0.04454 per EA · eff. 2026-09-23 filed
  • 72241-0005-11 · Modavar Pharmaceuticals LLC · $0.04454 per EA · eff. 2026-09-23 filed
  • 76282-0311-01 · Exelan Pharmaceuticals Inc. · $0.04454 per EA · eff. 2026-09-23 filed
  • 76282-0311-10 · Exelan Pharmaceuticals Inc. · $0.04454 per EA · eff. 2026-09-23 filed

Other strengths, forms and brands

3 other products in the NADAC file share the FDA nonproprietary name hydralazine hydrochloride with HYDRALAZINE 50 MG TABLET.

ProductPharmacies pay per unitMedicare per unit
HYDRALAZINE 10 MG TABLET
generic · tablet / tablet, film coated
$0.027 per EA filed
eff. 2026-09-23
$0.0887 per EA filed
Part D 2024 average
HYDRALAZINE 25 MG TABLET
generic · tablet / tablet, film coated
$0.03572 per EA filed
eff. 2026-09-23
$0.0887 per EA filed
Part D 2024 average
HYDRALAZINE 50 MG TABLET this page
generic · tablet / tablet, film coated
$0.04454 per EA filed
eff. 2026-09-23
$0.0887 per EA filed
Part D 2024 average
HYDRALAZINE 100 MG TABLET
generic · tablet / tablet, film coated
$0.0717 per EA filed
eff. 2026-09-23
$0.0887 per EA filed
Part D 2024 average

Part D is one average per brand and generic name, over every strength and form.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18

Compared with its class

The middle of its 21 NDCs’ NADAC prices is $0.04454 per EA filed.

Of the 7 other products in FDA’s Arteriolar Vasodilator class priced per EA, 5 have a higher middle NADAC price and 2 a lower one. The one in the middle is MINOXIDIL 2.5 MG TABLET, at $0.09821 per EA filed (eff. 2026-09-23).

Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

What Medicare paid

Medicare Part D paid $2.66 for 30 tablets, at an average of $0.0887 per EA in 2024 (2024-01-01 to 2024-12-31) for “Hydralazine HCl*” and “Hydralazine HCl”, every strength and form sold under that name together (Medicare Part D Spending by Drug, file of 2026-06-25).

That average covers 6,074,425 Part D claims (fills, including refills) for 2024-01-01 to 2024-12-31, across every maker, strength and form under the name.

19 of the product’s 21 NDCs have this Medicare figure; the other 2 do not, and the interactive card says why for each.

Medicare's price is not your price.

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.

Questions

Why is the comparison with Medicare for HYDRALAZINE 50 MG TABLET labelled estimated?
Beyond what the card shows, the records give these reasons: The Part D figure covers 2024-01-01 to 2024-12-31; the NADAC price is from the file of 2026-10-14. Part D spending basis, as the Part D record states it: Part D 2024 average spend per dosage unit for Hydralazine HCl* / Hydralazine HCl: all makers, strengths, forms and routes combined, claim-weighted; gross cost incl. dispensing fees and patient pay, before rebates. Unit taken as NADAC's EA. Joined on generic name. *: CMS says this average reflects multiple routes of administration, which may have different unit prices. Only NADAC NDCs whose FDA route includes ORAL point at this name (63 of the 70 the name join matched); NDCs of another route or with no known FDA route do not. 6 of the 63 NDCs that point at this name are not listed in the FDA NDC Directory as packages of their own; their route was taken from FDA's record for the same product (labeler and product code).